Page 216 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

192 Constantina Yiannakis, Lorna Ward and Matthew David Morgan

[51] Elzouki, A., Segelmark, M., Wieslander, J., et al. Strong link between the alpha 1-
antitrypsin PiZ allele and Wegener's granulomatosis. J. Intern. Med. 1994; 236: 543-
548.

[52] Esnault, V. L., Testa, A., Audrain, M., et al. Alpha 1-antitrypsin genetic polymorphism
in ANCA-positive systemic vasculitis. Kidney Int. 1993; 43:1329-1332.

[53] Savige, J. A., Chang, L., Cook, L., et al. Alpha 1-antitrypsin deficiency and anti-
proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated
systemic vasculitis. Clin. Exp. Immunol. 1995; 100:194-197.

[54] Segelmark, M., Elzouki, A. N., Wieslander, J., et al. The PiZ gene of alpha 1-
antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int.
1995; 48:844-850.

[55] Morris, H., Morgan, M. D., Wood, A. M., et al. ANCA-associated vasculitis is linked to
carriage of the Z allele of alpha antitrypsin and its polymers. Ann. Rheum. Dis. 2011;
70:1851-1856.

[56] Hogan, S. L., Satterly, K. K., Dooley, M. A., et al. Silica Exposure in Anti-Neutrophil
Cytoplasmic Autoantibody-Associated Glomerulonephritis and Lupus Nephritis. J. Am.
Soc. Nephrol. 2001; 12:134-142.

[57] Beaudreuil, S., Lasfargues, G., Laueriere, L., et al. Occupational exposure in ANCA-
positive patients: a case-control study. Kidney Int. 2005; 67:1961-1966.

[58] Stegeman, C. A., Tervaert, J. W., Sluiter, W. J., et al., WL; de Jong, P. E. and
Kallenberg, C. G. Association of chronic nasal carriage of Staphylococcus aureus and
higher relapse rates in Wegener granulomatosis. Ann. Intern. Med. 1994; 120:12-17.

[59] Stegeman, C. A., Cohen Tervaert, J. W., de Jong, P. E., et al. The Dutch Co-
trimoxazole Wegener Study Group. Trimethoprim-Sulfamethoxazole (Co-Trimoxazole)
for the Prevention of Relapses of Wegener's Granulomatosis. N. Engl. J. Med. 1996;
335: 16-20.

[60] Richter, A. G., Stockley, R. A., Harper, L., et al. Pulmonary infection in Wegener
granulomatosis and idiopathic pulmonary fibrosis. Thorax 2009; 64:692-697.

[61] Popa, E. R., Stegeman, C. A., Abdulahad, W. H., et al. Staphylococcal toxic-shock-
syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis.
Rheumatology 2007; 46:1029-1033.

[62] Kain, R., Exner, M., Brandes, R., et al. Molecular mimicry in pauci-immune focal
necrotizing glomerulonephritis. Nat. Med. 2008; 14:1088-1096.

[63] Kain, R., Tadema, H., McKinney, E. F., et al. High prevalence of autoantibodies to
hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J. Am. Soc.
Nephrol. 2012; 23:556-566.

[64] Roth, A. J., Brown, M. C., Smith, R. N., et al. Anti-LAMP-2 antibodies are not
prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis.
J. Am. Soc. Nephrol. 2012; 23:545-555.

[65] Slot, M. C., Links, T. P., Stegeman, C. A., et al. Occurrence of antineutrophil
cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism
treated with antithyroid drugs: A long-term followup study. Arthritis Rheum. 2005; 53:
108-113.

[66] Zhao, M. H., Chen, M., Gao, Y., et al. Propylthiouracil-induced anti-neutrophil
cytoplasmic antibody-associated vasculitis. Kidney Int. 2006; 69:1477-1481.

Complimentary Contributor Copy